Korro Bio raises $85 million in oversubscribed private placement Mar 9, 2026 07:30AM
Form SCHEDULE 13D/A Arcellx, Inc. Filed by: New Enterprise Associates 15, L.P. Feb 24, 2026 07:19PM
Form SCHEDULE 13D SpyGlass Pharma, Inc. Filed by: New Enterprise Associates 17, L.P. Feb 13, 2026 06:21PM
Form SCHEDULE 13D/A Trevi Therapeutics, Inc. Filed by: New Enterprise Associates 16, L.P. Feb 13, 2026 04:06PM
Form 3 SpyGlass Pharma, Inc. For: Feb 05 Filed by: New Enterprise Associates 17, L.P. Feb 5, 2026 04:05PM
View Older Stories

Jan 9, 2026 07:00AM Athira Pharma changes name to LeonaBio with new ticker LONA
Dec 18, 2025 07:03AM Athira Pharma secures license for breast cancer drug, raises $236 million
Dec 17, 2025 07:31AM Coursera to acquire Udemy in $2.5 billion all-stock deal
Nov 18, 2025 06:45AM UnitedHealth Group appoints former FDA commissioner to board
Nov 17, 2025 04:23PM Form SCHEDULE 13D/A Marker Therapeutics, Filed by: New Enterprise Associates 16, L.P.
Nov 17, 2025 09:00AM Coursera names Mike Foley as interim CFO
Nov 13, 2025 09:22AM Inventiva prices $150M american depositary share offering at $3.85
Nov 10, 2025 05:09PM Form SCHEDULE 13D/A MBX Biosciences, Inc. Filed by: New Enterprise Associates 17, L.P.
Oct 6, 2025 05:51PM Form SCHEDULE 13D/A NeueHealth, Inc. Filed by: New Enterprise Associates 17, L.P.
Oct 6, 2025 05:48PM Form 4 NeueHealth, Inc. For: Oct 02 Filed by: New Enterprise Associates 15, L.P.
Sep 11, 2025 09:02AM Veza enhances CrowdStrike integration for identity threat protection
Aug 19, 2025 06:54PM Form SCHEDULE 13D/A Adaptimmune Therapeutics Filed by: New Enterprise Associates 14, L.P.
Aug 18, 2025 05:34PM Form SCHEDULE 13D/A Marker Therapeutics, Filed by: New Enterprise Associates 16, L.P.
Aug 15, 2025 04:24PM Form 144 Adaptimmune Therapeutics Filed by: New Enterprise Associates 14, L.P.
Aug 15, 2025 04:23PM Form 144 Adaptimmune Therapeutics Filed by: New Enterprise Associates 14, L.P.
Aug 14, 2025 09:15PM Form SCHEDULE 13D/A Arcellx, Inc. Filed by: New Enterprise Associates 15, L.P.
Aug 13, 2025 07:00AM X4 Pharmaceuticals closes upsized $85 million private placement
Aug 12, 2025 07:01AM X4 Pharmaceuticals secures $60 million financing, replaces CEO and CFO
Aug 11, 2025 06:57PM Form SCHEDULE 13D/A Trevi Therapeutics, Inc. Filed by: New Enterprise Associates 16, L.P.
May 28, 2025 07:43PM Form SCHEDULE 13D/A BuzzFeed, Inc. Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
May 28, 2025 04:09PM ORIC Pharmaceuticals Inc. (ORIC) Announces $125 Million Private Placement at $6.50/sh
May 16, 2025 04:16PM Form SCHEDULE 13D/A Allakos Inc. Filed by: New Enterprise Associates 16, L.P.
May 13, 2025 04:15PM Form SCHEDULE 13G/A Sagimet Biosciences Inc. Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
May 12, 2025 04:15PM Form SCHEDULE 13D/A Arcellx, Inc. Filed by: New Enterprise Associates 15, L.P.
May 8, 2025 06:22PM Form SCHEDULE 13D/A BuzzFeed, Inc. Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
May 7, 2025 08:04PM Form SCHEDULE 13D/A Inventiva S.A. Filed by: New Enterprise Associates 17, L.P.
May 5, 2025 07:05AM IONQ Inc (IONQ) Appoints Jordan Shapiro as President and General Manager, Quantum Networking
Mar 28, 2025 04:14PM Form SCHEDULE 13D/A BuzzFeed, Inc. Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
Mar 26, 2025 06:44AM Canaccord Genuity Reiterates Hold Rating on Illumina (ILMN)
Mar 25, 2025 12:12PM Canaccord Genuity Reiterates Hold Rating on Illumina (ILMN)
Mar 25, 2025 09:01AM Illumina (ILMN) Board of Directors elects Dr. Scott Gottlieb Chair, Keith Meister to join Board of Directors
Mar 20, 2025 07:55PM Form SCHEDULE 13D/A Trevi Therapeutics, Inc. Filed by: New Enterprise Associates 16, L.P.
Mar 18, 2025 05:04PM Form SCHEDULE 13D/A BuzzFeed, Inc. Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
Mar 10, 2025 07:01PM Form SCHEDULE 13D/A Senti Biosciences, Inc. Filed by: New Enterprise Associates 15, L.P.
Feb 20, 2025 07:09PM Form SCHEDULE 13D/A CVRx, Inc. Filed by: NEW ENTERPRISE ASSOCIATES 10 L P
Feb 14, 2025 03:57PM Form SCHEDULE 13G/A Tuya Inc. Filed by: New Enterprise Associates 14, L.P.
Jan 7, 2025 06:58PM Form SCHEDULE 13D/A NEXTNAV INC. Filed by: New Enterprise Associates 14, L.P.
Jan 6, 2025 09:00AM Senti Biosciences (SNTI) Announces Additional $11.5M of Financing
Dec 26, 2024 03:09PM Form SCHEDULE 13D/A NeueHealth, Inc. Filed by: New Enterprise Associates 17, L.P.
Dec 23, 2024 04:30PM Form SCHEDULE 13D/A Marker Therapeutics, Filed by: New Enterprise Associates 16, L.P.
Dec 19, 2024 08:07AM Marker Therapeutics (MRKR) Announces $16.1 Million Private Placement
Dec 4, 2024 07:08PM Form SC 13D/A Senti Biosciences, Inc. Filed by: New Enterprise Associates 15, L.P.
Dec 2, 2024 07:11AM Senti Biosciences (SNTI) Announces Oversubscribed $37.6 Million Private Placement Equity Financing
Nov 18, 2024 06:40AM Tuya Inc. (TUYA) Announces Anchor Investment by 65 Equity Partners
Nov 8, 2024 06:58PM Form SC 13D/A Trevi Therapeutics, Inc. Filed by: New Enterprise Associates 16, L.P.
Nov 7, 2024 09:11PM Form SC 13D/A CVRx, Inc. Filed by: NEW ENTERPRISE ASSOCIATES 10 L P
Nov 5, 2024 05:36PM Form 144 CVRx, Inc. Filed by: NEW ENTERPRISE ASSOCIATES VIII L P
Nov 5, 2024 05:36PM Form 144 CVRx, Inc. Filed by: NEW ENTERPRISE ASSOCIATES 8A L P
Nov 1, 2024 04:10PM Form SC 13G/A Tuya Inc. Filed by: New Enterprise Associates 14, L.P.
Oct 21, 2024 08:55PM Form SC 13D/A Inventiva S.A. Filed by: New Enterprise Associates 17, L.P.
View Older Stories